Schlafstörungen bei Multipler Sklerose

Christian Veauthier

doi:10.1055/a-0817-2588

Nervenheilkunde, Table of Contents

Nervenheilkunde 2019; 38(03): 97-102
DOI: 10.1055/a-0817-2588

Schwerpunkt

Georg Thieme Verlag KG Stuttgart · New York

Schlafstörungen bei Multipler Sklerose

Christian Veauthier

¹Interdisziplinäres Schlafmedizinisches Zentrum, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin

› Author Affiliations

Abstract

Zusammenfassung

Gegenstand und Ziel: Patienten mit Multipler Sklerose (MS) leiden häufig an einer die Lebensqualität deutlich beeinträchtigenden Schlafstörung. Es soll ein Überblick über den gegenwärtigen Stand der Literatur gegeben werden. Material und Methoden: Übersichtsarbeit. Ergebnisse: Mehrere Studien haben bei der MS im Vergleich zur Allgemeinbevölkerung eine erhöhte Prävalenz für ein Restless-legs-Syndrom (RLS) gezeigt, im Besonderen bei MS-Patienten mit einem erhöhten Grad der Behinderung. Rund ein Viertel der MS-Patienten leidet an einer chronischen Insomnie. Es existieren symptomatische Formen der Narkolepsie und der REM-Schlaf-Verhaltensstörung (RBD), am ehesten durch akute Läsionen hervorgerufen. Ob Läsionen auch schlafbezogene Atmungsstörungen verursachen können, kann noch nicht ausreichend beurteilt werden. Schlussfolgerung und klinische Relevanz: Beim Neuauftreten einer Narkolepsie oder eines RBD sollte zügig eine kraniale Kernspintomografie mit Kontrastmittel erfolgen. Bei der Behandlung schlafmedizinischer Erkrankungen kommen die von den Fachgesellschaften empfohlenen Behandlungsrichtlinien zur Anwendung (die Behandlung unterscheidet sich bei MS-Patienten nicht grundsätzlich von der Behandlung dieser Erkrankungen in der Allgemeinbevölkerung). MS-Fatigue-Patienten sollten niedrigschwellig eine Polygrafie oder Polysomnografie erhalten.

Full Text

References

Literatur
1 Goodin DS. The causal cascade to multiple sclerosis: a model for MS pathogenesis. PLoS ONE 2009; 4 (Suppl. 02) e4565.
2 Borisow N, Döring A, Pfueller CF, Paul F, Dörr J, Hellwig K. Expert recommendations to personalization of medical approaches in treatment of multiple sclerosis: an overview of family planning and pregnancy. EPMA Journal 2012; 3 (Suppl. 01) 9.
3 Sinnecker T, Mittelstaedt P, Dörr J, Pfueller CF, Harms L, Niendorf T. et al. Multiple sclerosis lesions and irreversible brain tissue damage: a comparative ultrahigh-field strength magnetic resonance imaging study. Arch Neurol 2012; 69 (Suppl. 06) 739-45.
4 Behrens J, Pfüller C, Mansow-Model S, Otte K, Paul F, Brandt AU. Using perceptive computing in multiple sclerosis - the Short Maximum Speed Walk test. J Neuroeng Rehabil 2014; 11: 89.
5 Dörr J, Döring A, Paul F. Can we prevent or treat multiple sclerosis by individualised vitamin D supply?. EPMA J 2013; 4 (Suppl. 01) 4.
6 Endriz J, Ho PP, Steinman L. Time correlation between mono-nucleosis and initial symptoms of MS. Neurol Neuroimmunol Neuroinflamm 2017; 4 (Suppl. 03) e308.
7 Pfuhl C, Oechtering J, Rasche L, Gieß RM, Behrens JR, Wakonig K. et al. Association of serum Epstein-Barr nuclear antigen-1 antibodies and intrathecal immunoglobulin synthesis in early multiple sclerosis. J Neuroimmunol 2015; 285: 156-60.
8 Srinivasan S, Di Dario M, Russo A, Menon R, Brini E, Romeo M. et al. Dysregulation of MS risk genes and pathways at distinct stages of disease. Neurol Neuroimmunol Neuroinflamm 2017; 4 (Suppl. 03) e337.
9 Zivadinov R, Cerza N, Hagemeier J, Carl E, Badgett D, Ramasamy DP. et al. Humoral response to EBV is associated with cortical atrophy and lesion burden in patients with MS. Neu-rol Neuroimmunol Neuroinflamm 2016; 3 (Suppl. 01) e190.
10 Veauthier C. Fatigue bei Multipler Sklerose: Mögliche Ursachen und Zusammenhänge, sinnvolle Diagnostik und Therapie. Nervenheilkunde 2011; 30 (Suppl. 07) 470-5.
11 Veauthier C, Radbruch H, Gaede G, Pfueller C, Dorr J, Bell-mann-Strobl J. et al. Fatigue in multiple sclerosis is closely related to sleep disorders: a polysomnographic cross-sectional study. Multiple Sclerosis Journal 2011; 17 (Suppl. 05) 613-22.
12 Veauthier C, Gaede G, Radbruch H, Wernecke K-D, Paul F. Sleep Disorders Reduce Health-Related Quality of Life in Multiple Sclerosis (Nottingham Health Profile Data in Patients with Multiple Sclerosis). International Journal of Molecular Sciences 2015; 16 (Suppl. 07) 16514-28.
13 Veauthier C, Hasselmann H, Gold SM, Paul F. The Berlin Treatment Algorithm: recommendations for tailored innovative therapeutic strategies for multiple sclerosis-related fatigue. EPMA J 2016; 7: 25.
14 Achiron A, Givon U, Magalashvili D, Dolev M, Liraz Zaltzman S, Kalron A. et al. Effect of Alfacalcidol on multiple sclerosis-related fatigue: A randomized, double-blind placebo-controlled study. Multiple Sclerosis Journal 2015; 21 (Suppl. 06) 767-75.
15 Branas P. Treatments for fatigue in multiple sclerosis: a rapid and systematic review. [cited 2015 Dec 5]; Available from: http://www.hta.ac.uk/1167
16 Veauthier C, Gaede G, Radbruch H, Gottschalk S, Wernecke K-D, Paul F. Treatment of sleep disorders may improve fatigue in multiple sclerosis. Clinical Neurology and Neurosur-gery 2013; 115 (Suppl. 09) 1826-30.
17 Côté I, Trojan DA, Kaminska M, Cardoso M, Benedetti A, Weiss D. et al. Impact of sleep disorder treatment on fatigue in multiple sclerosis. Mult Scler 2013; 19 (Suppl. 04) 480-9.
18 Manconi M, Rocca MA, Ferini-Strambi L, Tortorella P, Agosta F, Comi G. et al. Restless legs syndrome is a common finding in multiple sclerosis and correlates with cervical cord damage. Mult Scler 2008; 14 (Suppl. 01) 86-93.
19 Li Y, Munger KL, Batool-Anwar S, De Vito K, Ascherio A, Gao X. Association of multiple sclerosis with restless legs syndrome and other sleep disorders in women. Neurology 2012; 78 (Suppl. 19) 1500-6.
20 Miri S, Rohani M, Sahraian MA, Zamani B, Shahidi GA, Sabet A. et al. Restless legs syndrome in Iranian patients with multiple sclerosis. Neurol Sci 2013; 34 (Suppl. 07) 1105-8.
21 Italian REMS Study Group. Manconi M, Ferini-Strambi L, Filippi M, Bonanni E, Iudice A. et al. Multicenter case-control study on restless legs syndrome in multiple sclerosis: the REMS study. Sleep 2008; 31 (Suppl. 07) 944-52.
22 Minár M, Petrlenicová D, Valkovic P. Higher prevalence of restless legs syndrome/Willis-Ekbom disease in multiple sclerosis patients is related to spinal cord lesions. Mult Scler Relat Disord 2017; 12: 54-8.
23 Veauthier C, Gaede G, Radbruch H, Sieb J-P, Wernecke K-D, Paul F. Periodic limb movements during REM sleep in multiple sclerosis: a previously undescribed entity. Neuropsychiat-ric Disease and Treatment 2015; 23: 23.
24 Viana P, Rodrigues E, Fernandes C, Matas A, Barreto R, Men-donça M. et al. InMS: Chronic insomnia disorder in multiple sclerosis - a Portuguese multicentre study on prevalence, subtypes, associated factors and impact on quality of life. Mult Scler Relat Disord 2015; 4 (Suppl. 05) 477-83.
25 Ferreira LN, Ferreira PL, Pereira LN, Oppe M. EQ-5D Portuguese population norms. Qual Life Res 2014; 23 (Suppl. 02) 425-30.
26 Dolan P. Modeling valuations for EuroQol health states. Med Care 1997; 35 (Suppl. 11) 1095-108.
27 Vitkova M, Rosenberger J, Gdovinova Z, Szilasiova J, Mikula P, Groothoff JW. et al. Poor sleep quality in patients with multiple sclerosis: gender differences. Brain and Behavior 2016; 6 (Suppl. 11) e00553.
28 Veauthier C, Paul F. Sleep disorders in multiple sclerosis and their relationship to fatigue. Sleep Medicine 2014; 15 (Suppl. 01) 5-14.
29 Braley TJ, Segal BM, Chervin RD. Hypnotic use and fatigue in multiple sclerosis. Sleep Medicine 2015; 16 (Suppl. 01) 131-7.
30 Veauthier C. Hypnotic use and multiple sclerosis related fatigue: a forgotten confounder. Sleep Medicine 2015; 16 (Suppl. 03) 319.
31 Morin CM, Stone J, Trinkle D, Mercer J, Remsberg S. Dysfunctional beliefs and attitudes about sleep among older adults with and without insomnia complaints. Psychol Aging 1993; 8 (Suppl. 03) 463-7.
32 Morin AK, Jarvis CI, Lynch AM. Therapeutic options for sleep-maintenance and sleep-onset insomnia. Pharmacothe-rapy 2007; 27 (Suppl. 01) 89-110.
33 Schellaert V, Labauge P, Lebrun C, Maudarbocus KH, Bernard J, Blache J-B. et al. Psychological processes associated with insomnia in patients with multiple sclerosis. Sleep 2018; 41(3).
34 de Bruin EJ, Bogels SM, Oort FJ, Meijer AM. Efficacy of Cognitive Behavioral Therapy for Insomnia in Adolescents: A Randomized Controlled Trial with Internet Therapy, Group Therapy and A Waiting List Condition. Sleep 2015; 38 (Suppl. 12) 1913-26.
35 Kaminska M, Kimoff R, Benedetti A, Robinson A, Bar-Or A, Lapierre Y. et al. Obstructive sleep apnea is associated with fatigue in multiple sclerosis. Multiple Sclerosis Journal 2012; 18 (Suppl. 08) 1159-69.
36 Kallweit U, Baumann CR, Harzheim M, Hidalgo H, Pöhlau D, Bassetti CL. et al. Fatigue and Sleep-Disordered Breathing in Multiple Sclerosis: A Clinically Relevant Association?. Multiple Sclerosis International 2013; 2013: 1-7.
37 Chen J-H, Liu X-Q, Sun H-Y, Huang Y. Sleep Disorders in Multiple Sclerosis in China: Clinical, Polysomnography Study, and Review of the Literature. Journal of Clinical Neurophysiology 2014; 31 (Suppl. 04) 375-81.
38 Blissitt PA. Sleep-Disordered Breathing After Stroke: Nursing Implications. Stroke 2017; 48 (Suppl. 03) e81-4.
39 Bogousslavsky J, Khurana R, Deruaz JP, Hornung JP, Regli F, Janzer R. et al. Respiratory failure and unilateral caudal brainstem infarction. Ann Neurol 1990; 28 (Suppl. 05) 668-73.
40 Devereaux MW, Keane JR, Davis RL. Automatic respiratory failure associated with infarction of the medulla. Report of two cases with pathologic study of one. Arch Neurol 1973; 29 (Suppl. 01) 46-52.
41 Levin BE, Margolis G. Acute failure of automatic respirations secondary to a unilateral brainstem infarct. Ann Neurol 1977; 1 (Suppl. 06) 583-6.
42 Lyons OD, Ryan CM. Sleep Apnea and Stroke. Can J Cardiol 2015; 31 (Suppl. 07) 918-27.
43 Braley TJ, Segal BM, Chervin RD. Sleep-disordered breathing in multiple sclerosis. Neurology 2012; 79 (Suppl. 09) 929-36.
44 Veauthier C, Paul F. Fatigue in multiple sclerosis: which patient should be referred to a sleep specialist?. Multiple Sclerosis Journal 2012; 18 (Suppl. 02) 248-9.
45 Kallweit U, Bassetti CLA, Oberholzer M, Fronczek R, Béguin M, Strub M. et al. Coexisting narcolepsy (with and without cataplexy) and multiple sclerosis: Six new cases and a literature review. J Neurol 2018; 265 (Suppl. 09) 2071-8.
46 Veauthier C. Sleep Disorders in Multiple Sclerosis. Review. Current Neurology and Neuroscience Reports [Internet]. 2015; 15(5). Available from: http://link.springer.com/10.1007/s11910-015-0546-0.
47 Browne P, Chandraratna D, Angood C, Tremlett H, Baker C, Taylor BV. et al. Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity. Neurology 2014; 83 (Suppl. 11) 1022-4.
48 Evans C, Beland S-G, Kulaga S, Wolfson C, Kingwell E, Marriott J. et al. Incidence and Prevalence of Multiple Sclerosis in the Americas: A Systematic Review. Neuroepidemiology 2013; 40 (Suppl. 03) 195-210.
49 Riemann D, Baglioni C, Bassetti C, Bjorvatn B, Dolenc Groselj L, Ellis JG. et al. European guideline for the diagnosis and treatment of insomnia. J Sleep Res 2017 Sep 5; E-pub.
50 Aurora RN, Kristo DA, Bista SR, Rowley JA, Zak RS, Casey KR. et al. Update to the AASM Clinical Practice Guideline: “The Treatment of Restless Legs Syndrome and Periodic Limb Movement Disorder in Adults—An Update for 2012: Practice Parameters with an Evidence-Based Systematic Review and Meta-Analyses.”. SLEEP [Internet]. 2012 Aug 1 [cited 2015 Nov 26]; Available from: http://www.journalsleep.org/View-Abstract.aspx?pid=28591
51 Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med 2017; 13 (Suppl. 02) 307-49.
52 Högl B, Stefani A. REM sleep behavior disorder (RBD): Update on diagnosis and treatment. Somnologie 2017; 21 Suppl 1 1-8.
53 Billiard M, Bassetti C, Dauvilliers Y, Dolenc-Groselj L, Lammers GJ, Mayer G. et al. EFNS guidelines on management of narcolepsy. Eur J Neurol 2006; 13 (Suppl. 10) 1035-48.
54 Richtlinie des Gemeinsamen Bundesausschusses zu Untersu-chungs- und Behandlungsmethoden der vertragsärztlichen Versorgung. Berlin: Bundesanzeiger; 2016
55 Garcia-Borreguero D, Silber MH, Winkelman JW, Högl B, Bainbridge J, Buchfuhrer M. et al. Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation. Sleep Med 2016; 21: 1-11.